Log In
BCIQ
Print this Print this
 

Brexidol, piroxicam-beta-cyclodextrin

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionPiroxicam-beta-cyclodextrin
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat mild to severe pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today